Selleckchem Inc

Bio Active Compounds.

Recent products

Enapotamab vedotin

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Laprituximab emtansine

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Sofituzumab vedotin

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Lorvotuzumab mertansine

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Ozuriftamab vedotin

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Cantuzumab ravtansine

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Cantuzumab mertansine

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Vadastuximab talirine

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Serclutamab talirine

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Tusamitamab ravtansine

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Cetuximab-MMAE

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Codrituzumab-MMAE

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Sirtratumab vedotin

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Pinatuzumab vedotin

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Iladatuzumab vedotin

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

Farletuzumab-MMAE

Price range: £794.00 through £2,432.00 / 1,111.603,404.80 Standard

1 647 648 649 705